https://www.tipranks.com/news/the-fly/masimo-price-target-raised-to-170-from-166-at-btig

BTIG analyst Marie Thibault raised the firm’s price target on Masimo to $170 from $166 and keeps a Buy rating on the shares as part of a broader research note previewing Q3 results in MedTech. The sector had “solid returns” as Providers outperformed among healthcare sub-sectors at 10.5% for iShares U.S. Healthcare Providers ETF (IHF), and these results track largely in line with fundamental feedback during Q3 as procedure volumes have been healthy and demand is strong, the analyst tells investors in a research note. Channel checks in many sub-sectors also point to sustained procedure demand continuing into 2025 as demographics and low unemployment provide support, the firm added.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on MASI:

Apple rethinking approach to headsets, Bloomberg reports Micron reports Q4 beat, Pfizer withdraws Oxbryta: Morning Buzz Masimo founder Kiani demands $400M in payouts after board ousting, FT says SAP under DOJ probe, Adobe sees record holiday season sales: Morning Buzz Masimo Announces Executive Shift and Strategic Business Review